Tag Innovation & tech transfer

Invitrogen, WARF sign license agreement for human embryonic stem cells

Invitrogen Corp. and the Wisconsin Alumni Research Foundation announced today (May 8) that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools.

WARF licenses influenza vaccine technology to FluGen

The Wisconsin Alumni Research Foundation and FluGen have signed license agreements for a technology that has the potential to significantly improve the way influenza vaccines are manufactured.

TomoTherapy’s Mackie to speak on faculty entrepreneurship

Thomas Rockwell Mackie, co-founder, chairman of the board and director of research at TomoTherapy, will speak on faculty entrepreneurship on Wednesday, April 2, beginning at 5 p.m. The event, part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation, is free and open to the public.

WARF announces new hires and promotions

The Wisconsin Alumni Research Foundation (WARF) has announced promotions for Michael E. Falk and Emily Bauer, and the hires of a communications director, Janet L. Kelly, and two licensing professionals, Craig Heim for start-up companies, and Mark Stoveken for pharmaceutical licensing.

Basic research robust in face of more university patenting

A UW–Madison study of more than 1,800 U.S. life scientists found that, despite an explosion in academic patenting in recent years, most life science professors still do research the "old-fashioned" way: they win federal grants, publish results in scientific journals, and graduate Ph.D. students.

State seeds stem-cell company based on UW–Madison research

Governor Jim Doyle today (May 14) gave a $1 million boost to a University of Wisconsin–Madison spin-off company during a visit to the campus lab that gave birth to its technology.